Quick10K

⚲

Gala Pharmaceutical

Filings

10-Q	2019-05-31	Filed 2019-07-23
10-Q	2019-02-28	Filed 2019-04-30
10-K	2018-11-30	Filed 2019-04-15
10-Q	2018-08-31	Filed 2018-10-26
10-Q	2018-05-31	Filed 2018-08-01
10-Q	2018-02-28	Filed 2018-05-08
10-K	2017-11-30	Filed 2018-04-06
10-Q	2017-08-31	Filed 2017-10-19
10-Q	2017-05-31	Filed 2017-07-28
10-Q	2017-02-28	Filed 2017-04-18
10-K	2016-11-30	Filed 2017-03-09
10-Q	2016-08-31	Filed 2016-11-04
10-Q	2016-05-31	Filed 2016-07-15
10-Q	2016-02-29	Filed 2016-05-10
10-K	2015-11-30	Filed 2016-03-22
10-Q	2015-08-31	Filed 2015-10-20
10-Q	2015-05-31	Filed 2015-07-30
10-Q	2015-02-28	Filed 2015-04-22
10-K	2014-11-30	Filed 2015-03-13
10-Q	2014-08-31	Filed 2014-10-20
10-Q	2014-05-31	Filed 2014-07-18
10-Q	2014-02-28	Filed 2014-04-28
10-K	2013-11-30	Filed 2014-04-18
10-Q	2013-08-31	Filed 2013-10-29
10-Q	2013-02-28	Filed 2013-04-15
10-K	2012-11-30	Filed 2013-03-14
10-Q	2012-08-31	Filed 2012-10-15
10-Q	2012-05-31	Filed 2012-07-18
10-Q	2012-02-29	Filed 2012-04-23
10-K	2011-11-30	Filed 2012-03-13
10-Q	2011-08-31	Filed 2011-11-09

Reports

8-K	2020-04-29
8-K	2019-10-16
8-K	2019-03-19
8-K	2019-01-10
8-K	2019-01-02
8-K	2018-11-30
8-K	2018-09-26
8-K	2018-07-09
8-K	2018-06-20
8-K	2018-01-10

Gala Pharmaceutical Financials

GLAG Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546,418	322,654	0	0	0	0	-853,740
1 800 Flowers Com (FLWS)	944,324	42%	13.3	6%	664,955	335,559	1,266,390	533,727	36,761	75,090	1,000,932
10x Genomics (TXG)	4,804,979	75%	-490.3	-2%	572,815	151,367	61,207	45,727	-9,603	-8,887	4,357,180
12 Retech (RETC)	0	32%	-0.1	-1,385%	1,118	20,421	625	199	-15,491	-14,800	966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	33,711	0%	0.4	-5%	164,088	108,405	18,194	0	-7,969	-8,017	-2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	18,527	23,194	27,219	6,699	-2,862	-1,433	3,396
1895 Bancorp of Wisconsin (BCOW)	46,152,715		12,508.1	-0%	441,187	382,722	0	0	-44	3,689	46,142,359
1st Constitution Bancorp (FCCY)	164,504	0%	4.4	1%	1,342,565	1,204,038	490	0	13,787	32,503	143,748
1st Franklin Financial (FFC)	3,551		-0.6	7%	905,107	644,730	0	0	62,078	80,004	-45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200,033		7.9	1%	6,691,070	5,858,028	0	0	70,061	136,342	1,072,548
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	1,849	0	0	-1,663	-1,654	250
21Vianet Group (VNET)	6,005,116			0%	11,150,717	5,787,533	0	0	0	0	3,344,095
22nd Century (XXII)	301,854	1%	-14.1	-36%	61,864	6,554	25,706	304	-22,433	-21,464	301,826
1Life Healthcare (ONEM)


Balance Sheet ($'000)	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31
Cash	3	0		0	25	12	6	0	0	0	0	0	0	0	0	0	2	14	2	2	11	0	252	61	8	0	39	15	116	179	37
Accounts Receivable
Inventory																	3	2	2	7	2	2	2	2	2	2	2	2	0	0
PP&E			1	1	0	0	0	0	0															100	53	53	53	51	51	58	322
Assets	4	1	1	1	25	12	6	1	0	0	0	53	0	16	194	115	7	30	14	9	13	2	359	361	108	321	266	248	262	283	386
Accounts Payable					5	1	4
Long-Term Debt																													244	241	276
Liabilities	0	0	1	20	26	23	26	26	37	46	27	117	193	241	303	389	471	354	388	433	461	482	499	752	1,014	956	967	1,455	1,121	1,633	3,464
Stockholders' Equity	4	1	0	-19	-1	-11	-20	-25	-37	-46	-27	-64	-193	-225	-109	-274	-464	-323	-374	-424	-448	-479	-140	-391	-906	-635	-697	-1,198	-811	-1,281	-2,991


Income Statement ($'000)	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31
Revenue		0	0	0		0	0	0	0	0	0	0	0	0	0	0											5	0		0	0
Cost of Revenue				0		0	0																				3	0		0	0
Gross Profit				0		0	0																				1	0		0	0
R&D
SG&A		3	1	19	29	10	8	6	1	5	2	21	26	22	36	19	3	12	18	9	12	11	15	29	36	36	109	20		39	77
Tax		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0		0	0
Net Income		-3	-1	-19	-29	-10	-8	-6	-12	-8	-5	-37	-228	-260	-96	-208	-116	-45	-51	-50	-24	-31	-373	-695	-882	-583	-394	-712		-577	-2,113


Cash Flow ($'000)	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31
Cash Operating		-3	-0	0	-22	-13	-6	-5	-0	-3	7	-29	-36	-39	-24	-51	-13	-2	-37	-22	-10	-23	-17	-186	-98	-83	-161	-100		-108	-99
Cash Investing		0	0	0	0	0	0	0	0	0	0	-53	-137	-12	5	0	7	0	0	0	0			-115	-5			0		-7	-264
Cash Financing		0	0	0	47	0	0	0	0	31	-7	82	173	51	19	51	8	14	25	22	19	12	274	110	50	75	200	75		178	221